The NEPHRO CRRT pivotal trial has now reached approximately 25% enrollment, driven by the recent acceleration in the recruitment rate from new profile clinical sites On track for planned study ...
Kurnool: In a remarkable medical achievement, doctors at KIMS Hospital, Kurnool, successfully saved the life of 47-year-old ...
Among hospitalized patients with septic shock, those with vs without low serum chloride levels or requirement for continuous renal replacement therapy (CRRT) have higher mortality ...
The U.S. Food and Drug Administration (FDA) agreed to reduce the number of patients in the NEPHRO CRRT study from 166 to 70 patients, of which 6 patients are already enrolled Talphera believes the ...
The need for continuous renal replacement therapy may be associated with high risk of mortality among adult patients with acetaminophen-induced acute liver failure. Patients with acute liver failure ...
(RTTNews) - Specialty pharmaceutical company Talphera, Inc. (TLPH), Monday announced its agreement with the FDA to reduce the size of the NEPHRO CRRT study to 70 patients from the 166 previously ...
NEPHRO CRRT clinical study expected to be completed this year Cash and investments of $21.1 million at March 31, 2026 Conference call and webcast to be held on Wednesday ...
SAN MATEO, Calif., Aug. 25, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results